Guo, J.-t. | bioRxiv Science

bioRxiv2021

Protein interaction analysis of Plasmodium falciparum circumsporozoite protein variants with human immunoproteins explains RTS,S vaccine efficacy in Ghana

BackgroundThe worlds first malaria vaccine RTS,S provides only partial protection against Plasmodium falciparum infections. The explanation for such low efficacy is unclear. This study examined the associations of parasite genetic variations with binding affinity to human immunological proteins including human leukocyte antigen (HLA) and T cell receptors (TCR) involved in RTS,S-induced immune responses. MethodsMultiplicity of infections was determined by amplicon deep sequencing of merozoite surface protein 1 (PfMSP1). Genetic variations in the C-terminal of circumsporozoite protein (PfMSP1) gene were examined across 88 samples of P. falciparum collected from high and low transmission settings of Ghana. Binding interactions of PfMSP1 variants and HLA/TCR were analyzed using NetChop and HADDOCK predictions. Anti-CSP IgG levels were measured by ELISA in a subset of 10 samples. FindingsHigh polyclonality was detected among P. falciparum infections. A total 27 CSP haplotypes were detected among samples. A significant correlation was detected between the CSP and MSP multiplicity of infection (MOI). No clear clustering of haplotypes was observed by geographic regions. The number of genetic differences in PfCSP between 3D7 and non-3D7 variants does not influence binding interactions to HLA/T cells nor anti-CSP IgG levels. Nevertheless, PfCSP peptide length significantly affects its molecular weight and binding affinity to the HLA. InterpretationsThe presence of multiple non-3D7 strains among P. falciparum infections in Ghana impact the effectiveness of RTS,S. Longer PfCSP peptides may elicit a stronger immune response and should be considered in future version RTS,S. The molecular mechanisms of RTS,S cell-mediated immune responses related to longer CSP peptides warrants further investigations.

bioinformatics↗

bioRxiv2021

Prevalent uses of exons as regulatory sequences are possible and inevitable

BackgroundIt has long been known that exons can be used as cis-regulatory sequences such as enhancers. However, the prevalence of such dual-use of exons and how they evolve remain elusive. Our recently predicted highly accurate, large sets of cis-regulatory module candidates (CRMCs) and non-CRMCs in the human genome positioned us to address these questions. ResultsWe found that exonic transcription factor binding sites (TFBSs) occupied at least a third of the total exon lengths, and 96.7% of genes had exonic TFBSs. Both A/T and C/G in exonic TFBSs are more likely under evolutionary constraints than those in non-CRMC exons. Interestingly, exonic TFBSs in codons tend to encode loops rather than more critical helices and strands in protein structures, while exonic TFBSs in untranslated regions (UTRs) tend to avoid positions where known UTR-related functions are located. Moreover, active exonic TFBSs tend to be in close physical proximity to distal promoters whose immediately downstream genes have elevated transcription levels, suggesting that they might be involved in transcriptional regulation of target genes. It is highly possible that less critical positions in an exon that is physically close to a promoter can evolve into a TFBS when no non-exonic sequences are physically available to the promoter. ConclusionsExonic TFBSs might be more prevalent than originally thought and are likely in dual-use. Possible detrimental effects caused by such dual-use can be reduced by using less critical exonic positions. We proposed a parsimonious model to explain how a stretch of codons evolve into a TFBS.

evolutionary biology↗